You are here:HomeMarket

Dr Reddy's get U.S. nod for blood pressure tablets

A Dreamliner in Air India colours at an airport in Washington

close

Mumbai: U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.

Shares of the company were up 1.51 percent at Rs 1,671.



Copyright Thomson Reuters 2012



Story first published on: August 03, 2012 13:02 (IST)

For Profit Update,
Follow NDTV on Pinterest

Post your comments:

Social Sharing

Advertisement

From Reuters

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2013. All rights reserved.